WallStreetZenWallStreetZen

NYSE: BAK
Braskem Sa Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for BAK

Based on 2 analysts offering 12 month price targets for Braskem Sa

Min Forecast
$3.80+10.14%
Avg Forecast
$4.40+27.54%
Max Forecast
$5.00+44.93%

Should I buy or sell BAK stock?

Based on 2 analysts offering ratings for Braskem Sa.

Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
2 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their BAK stock forecasts and price targets.

BAK stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-09-26
lockedlocked$00.00+00.00%2025-08-27

1 of 1

Forecast return on equity

Is BAK forecast to generate an efficient return?

Insufficient data to display

Forecast return on assets

Is BAK forecast to generate an efficient return on assets?

Company
-4.97%
Industry
1.85%
BAK is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

BAK earnings per share forecast

What is BAK's earnings per share in the next 2 years based on estimates from 11 analysts?

Avg 1 year Forecast
-$4.54
Avg 2 year Forecast
-$1.10

BAK revenue forecast

What is BAK's revenue in the next 2 years based on estimates from 12 analysts?

Avg 1 year Forecast
$81.8B+553.31%
Avg 2 year Forecast
$88.9B+609.41%
BAK's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

BAK revenue growth forecast

How is BAK forecast to perform vs Chemicals companies and vs the US market?

Company
508.91%
Industry
20.2%
Market
1,542.52%
BAK's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
BAK's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

BAK vs Chemical Stocks

TickerPricePrice TargetUp/downsideConsensus
BAK$3.45$4.40+27.54%Hold
REX$34.59N/AN/A
TROX$6.91$5.65-18.23%Buy
GPRE$12.66$11.50-9.16%Hold
WLKP$21.61N/AN/A
View Top Chemical Stocks

Braskem Sa Stock Forecast FAQ

Is Braskem Sa Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NYSE: BAK) stock is to Hold BAK stock.

Out of 2 analysts, 0 (0%) are recommending BAK as a Strong Buy, 0 (0%) are recommending BAK as a Buy, 2 (100%) are recommending BAK as a Hold, 0 (0%) are recommending BAK as a Sell, and 0 (0%) are recommending BAK as a Strong Sell.

If you're new to stock investing, here's how to buy Braskem Sa stock.

What is BAK's earnings growth forecast for 2026-2027?

(NYSE: BAK) Braskem Sa's forecast annual earnings growth rate of N/A is not forecast to beat the US Chemicals industry's average forecast earnings growth rate of 2.78%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 3,359.17%.

Braskem Sa's earnings in 2026 is -$1,965,277,777.On average, 11 Wall Street analysts forecast BAK's earnings for 2026 to be -$3,615,337,527, with the lowest BAK earnings forecast at -$6,109,481,957, and the highest BAK earnings forecast at -$1,832,382,206.

In 2027, BAK is forecast to generate -$875,732,806 in earnings, with the lowest earnings forecast at -$3,062,952,219 and the highest earnings forecast at $1,657,395,087.

What is BAK's revenue growth forecast for 2026-2027?

(NYSE: BAK) Braskem Sa's forecast annual revenue growth rate of 508.91% is forecast to beat the US Chemicals industry's average forecast revenue growth rate of 20.2%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 1,542.52%.

Braskem Sa's revenue in 2026 is $13,439,409,722.On average, 12 Wall Street analysts forecast BAK's revenue for 2026 to be $65,238,705,887,556, with the lowest BAK revenue forecast at $57,740,966,208,786, and the highest BAK revenue forecast at $75,167,132,252,192.

In 2027, BAK is forecast to generate $70,840,685,337,074 in revenue, with the lowest revenue forecast at $60,642,005,516,712 and the highest revenue forecast at $78,904,442,577,984.

What is BAK's forecast return on assets (ROA) for 2026-2027?

(NYSE: BAK) forecast ROA is -4.97%, which is lower than the forecast US Chemicals industry average of 1.85%.

What is BAK's Price Target?

According to 2 Wall Street analysts that have issued a 1 year BAK price target, the average BAK price target is $4.40, with the highest BAK stock price forecast at $5.00 and the lowest BAK stock price forecast at $3.80.

On average, Wall Street analysts predict that Braskem Sa's share price could reach $4.40 by Sep 26, 2026. The average Braskem Sa stock price prediction forecasts a potential upside of 27.54% from the current BAK share price of $3.45.

What is BAK's Earnings Per Share (EPS) forecast for 2026-2027?

(NYSE: BAK) Braskem Sa's current Earnings Per Share (EPS) is -$4.93. On average, analysts forecast that BAK's EPS will be -$4.54 for 2026, with the lowest EPS forecast at -$7.66, and the highest EPS forecast at -$2.30. In 2027, BAK's EPS is forecast to hit -$1.10 (min: -$3.84, max: $2.08).

What is BAK's forecast return on equity (ROE) for 2026-2027?

(NYSE: BAK) forecast ROE is N/A, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.